What Changed in Melanoma Immunotherapy Over 20 Years? / cancer, ESMO, immune response, Melanoma, Nicholas Restifo, OncoDaily, ...
Omid Hamid Honors Jeffrey Weber’s Legacy in Cancer Immunotherapy / Adjuvant Therapy, ASCO, cancer, cancer vaccines, ESMO, ...
Gustave Roussy International – Egypt shared on LinkedIn: “Empowering African healthcare professionals through education, collaboration, and excellence in breast cancer care ...
City of Hope / cancer, City of Hope, clinical trials, esmo 2026, ESMO26, kidney cancer, kidney cancer research, ...
VIKTORIA-1 shows gedatolisib maintained strong PFS benefit over alpelisib in PIK3CA-mutant HR+/HER2− breast cancer, including ...
AI Can Guide Cancer Drug Discovery, but Clinical Validation Still Matters / AI, artificial intelligence, cancer, clinical ...
Izalontamab Brengitecan Improves PFS in HR+/HER2− Breast Cancer in China / Bihui Li, Bin Liu, Bing Zhao, Binghe Xu, cancer, ...
COCOON shows lazertinib lead-in plus simplified prophylaxis reduced grade ≥2 skin toxicity to 18% with SC amivantamab in EGFR ...
CROWN ctDNA data link early lorlatinib progression to genomic complexity, TP53 and bypass pathways rather than new ALK ...
At the Community Oncology Global Congress (COGC 2026), organized by OncoDaily, Amol Akhade, Senior Consultant in Medical ...
MONARCH shows median OS of 32.1 vs 24.6 months with abemaciclib after prior CDK4/6 therapy, but the survival difference was ...
Princess Ghida Talal։ Our Heartfelt Thanks to Everyone Who Believed in Our Mission and Stood by Our Patients / cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results